openPR Logo
Press release

Clopidogrel Market Competitive Analysis by 2025 : Pfizer, Dr Reddy’s, Apotex Corp, Roxane Laboratories, Aurobindo Pharma

04-05-2019 12:55 PM CET | Health & Medicine

Press release from: TMR Research

Clopidogrel Market Competitive Analysis by 2025 : Pfizer, Dr

Global Clopidogrel Market: Snapshot

Clopidogrel is an antiplatelet agent of thienopyridine, which is primarily used to prevent the blood clots and help against cardiovascular problems associated with the blood clotting. The medications for inhibiting blood clots after a recent heart stroke also use clopidogrel, which is a white colored powder that is insoluble in water at neutral pH but freely soluble at pH1. Clopidogrel was the second most successful drug trailing behind Pfizer’s Lipito in 2010. Sold under the brand name Plavix, and marketed by Sanofi and Bristol-Myers Squibb, the demand for clopidogrel is escalating due to the increasing number of heart attack cases across the globe.

The patent of clopidogrel manufacturing got expires on Market 31, 2012 and is expected to prompt pharmaceutical companies to venture into clopidogrel drug manufacturing. Moreover, companies such as Dr. Reddy’s have acquired the approval to manufacture clopidogrel 300mg. Furthermore, several other organizations such as Roxane Laboratories, Aurobindo Pharma, Sun Pharma, Torrent Pharmaceuticals, and Apotex Crop have gained approval for marketing clopidogrel 75mg. Clopidogrel is also used with aspirin to treat worsening chest pain and to keep blood vessels open and present blood clots after certain heart related operations.

Request Sample Copy of the Report @
www.tmrresearch.com/sample/sample?flag=B&rep_id=6

Global Clopidogrel Market: Trends and Prospects

The primary factor for the increased demand for clopidogrel is the mounting population across the world who are suffering from cardiovascular diseases and related problems. Additionally, the changing lifestyle and increase in number of patients related with cardiovascular diseases among the emerging economies in the Asia Pacific region are also expected to be the major consumers for clopidogrel in the next six years. Moreover, the patent expiry of clopidogrel drug is anticipated to open floodgates for various pharmaceutical companies to venture into production of clopidogrel drug.

According to the World Heart Federation, nearly 15 million people suffer from heart attack or related problems globally. Out of these, roughly six million of these patients die while another five million are disabled permanently. This vast patient base is the primary factor that will sustain the demand during the forecast period.

Request TOC of the Report @
www.tmrresearch.com/sample/sample?flag=T&rep_id=6

Global Clopidogrel Market: Geographical Outlook

Currently, North America and Europe contribute to the maximum demand for clopidogrel, owing to factors such as robust healthcare infrastructure and high affordability of the residents in this region. However, several countries in the region of Asia Pacific, such as China, India, and Japan are aggressively working towards improving their healthcare sector with the help of favorable policies by the localized governments and increasing disposable income among the urban population. Asia Pacific is home for nearly half of the world’s population, which makes for a high quantity of patient base. Additionally, these regions also have skilled labor at low cost which is encouraging players in the market to invest actively and tap the unmet demand.

Some of the key players in the global clopidogrel market are Pfizer, Dr Reddy’s, Apotex Corp, Roxane Laboratories, Aurobindo Pharma, Torrent Pharmaceuticals and Sun Pharma.

About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clopidogrel Market Competitive Analysis by 2025 : Pfizer, Dr Reddy’s, Apotex Corp, Roxane Laboratories, Aurobindo Pharma here

News-ID: 1690539 • Views: 203

More Releases from TMR Research

Terrestrial Trunked Radio (TETRA) Market | Space Corporation (France), Bitea Lim …
Terrestrial Trunked Radio (TETRA) Market: Overview The rising demand for higher level of encryption for voice to meet the security needs for public safety organizations is boosting the global terrestrial trunked radio (TETRA) market. The ability of terrestrial trunked radios to transfer data quickly as compared to the mobile communications earlier is also boosting their demand. Terrestrial trunked radio is a private, digital mobile radiotechnology, finding its application in medical, transport,
Timing Devices Market - Survey On Future Scope 2025 | Texas Instruments Incorpor …
Global Timing Devices Market: Overview The three broad segments of timing devices are semiconductor clocks, oscillators, and resonators. Timing devices are the semiconductor components bringing about timely performance of electronic products. Small timing devices are usually pocket instruments and wrist instruments and the larger ones are typically table and the panel-mounted units, which includes demonstrational timers. Timing devices run on electricity and have a digital display. Akin to clocks and the watches,
Global Smoothies Market Analysis Report 2018 Revealing Top Trends, Growth Factor …
Global Smoothies Market: Overview A smoothie is a thick drink made with raw fruit or vegetables mixed. A smoothie that is rich in vitamins, fibers and other nutrients is also like a healthy smoothie. Healthy smoothies are generally obtained from seeds, plants and fruits. Smoothies are mainly produced from fruits and vegetables so that the nutrients and vitamins are vital. In order to clean up and detox the body, a correct
Emulsifying Wax Market - Comparative Analysis 2028 | Sichuan Zhongguang Lightnin …
Global Emulsifying Wax Market: Overview Emulsifying wax is the low-alcoholic odor white wax. When wax material is handled with detergents, emulsifying wax is produced, which helps to create micelle. As the population grows old and the lifestyle changes, people experience hectic and stressful lives that can produce wrinkles and dark circles that are a sign of early aging. Consumers are more aware of their health and appearance today. In many cosmetic

All 26595 Releases


More Releases for Clopidogrel

Global Clopidogrel Market Insights, Forecast
Clopidogrel, sold as the brandname Plavix among others, is an antiplatelet medication that is used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent. It is taken by mouth. Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians
Clopidogrel Market - Top leading manufacturers 2025 | Pfizer, Dr Reddy’s
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are
Clopidogrel Market blustery by 2025
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are
Clopidogrel Market - Future demand Foreseen by 2025
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are
Clopidogrel Market - Geographical Outlook and Forecast 2017 - 2025
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are
Clopidogrel Market - Growth Prospects In Upcoming Years upto 2025
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are